US 9890213
Methods for the treatment of B cell-mediated inflammatory diseases
granted A61KA61K2039/505A61P
Quick answer
US patent 9890213 (Methods for the treatment of B cell-mediated inflammatory diseases) held by VACCINEX, INC. expires Mon Feb 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- VACCINEX, INC.
- Grant date
- Tue Feb 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K2039/505, A61P, A61P37/00, A61P37/06